All In Biotech

Drug Trial Radar · NCT04731558

Pre- Vs Postoperative Thromboprophylaxis for Liver Resection

Pre- Vs Postoperative Thromboprophylaxis for Liver Resection - a Prospective, Multicenter, Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Feb 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 1,012 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,012

Planned (sponsor's estimate)

Start

Feb 10, 2021

Primary completion

Feb 2027

Study completion Mar 2027

Sponsor

Lead sponsor
Helsinki University Central HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Academy of Finland; The Finnish Medical Association
First posted
Feb 1, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Thromboprophylaxis for liver surgery can be commenced either preoperatively or postoperatively. Despite a clear trade-off between thrombosis and bleeding in liver surgery patients, there is no international consensus when thrombosis prophylaxis should be commenced in patients undergoing liver surgery. As far as we know, there are no prospective randomized trials in this field, and current guidelines are unfortunately based on very low quality evidence, that is, a few retrospective studies and expert opinion. Both American and European thromboprophylaxis guidelines for abdominal cancer surgery support the preoperative initiation of thromboprophylaxis, but these guidelines do not specifically address the increased bleeding risk associated with liver surgery. On the contrary, Dutch guidelines recommend postoperative thromboprophylaxis only, because of lack of evidence for preoperative thromboprophylaxis. Traditionally, many liver surgery units have been reluctant in using preoperative thromboprophylaxis due to the potentially increased risk of bleeding complications. Enhanced Recovery After Surgery (ERAS) Society Guidelines recommend preoperative thromboprophylaxis in liver surgery, but the guidelines provide no supporting evidence for this recommendation. Overall, the amount of evidence is scarce and somewhat contradictory in this clinically relevant field of thromboprophylaxis in liver surgery. The aim of this study is to compare pre- and postoperatively initiated thromboprophylaxis regimens in liver surgery in a randomized controlled trial.

Conditions

  • Liver Cancer
  • Surgery
  • Thrombosis, Deep Vein
  • Embolism, Pulmonary
  • Bleeding

Interventions

  • enoxaparin or tinzaparin or dalteparinDrug

    Thromboprophylaxis initiated approximately 14 hours prior to the planned liver resection skin incision. Thromboprophylaxis can be initiated using enoxaparin (20 - 40 mg), tinzaparin (2500 - 4500 IU), or dalteparin (2500 - 5000 IU), with the dose based on patient's renal function

  • No interventionDrug

    No preoperative thromboprophylaxis.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Venous thromboembolismsTime frame: within 30 days from liver resection

Locations

7 sites in 2 countries. Site status is shown where the registry gives one.

  • Helsinki University Hospital

    Helsinki, Finland · Recruiting

  • Kuopio University Hospital

    Kuopio, Finland · Recruiting

  • Oulu University Hospital

    Oulu, Finland · Not yet recruiting

  • Tampere University Hospital

    Tampere, Finland · Recruiting

  • Turku University Hospital

    Turku, Finland · Not yet recruiting

  • Oslo University Hospital

    Oslo, Norway · Recruiting

  • University Hospital of North Norway

    Tromsø, Norway · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.